Kotaru Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 11-01-2025
- Paid Up Capital ₹ 1.80 Cr
as on 11-01-2025
- Company Age 8 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.61 Cr
as on 11-01-2025
- Revenue 31.66%
(FY 2022)
- Profit 29.39%
(FY 2022)
- Ebitda 30.82%
(FY 2022)
- Net Worth 81.12%
(FY 2022)
- Total Assets -4.95%
(FY 2022)
About Kotaru Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.80 Cr.
The company currently has active open charges totaling ₹7.61 Cr.
Srinivasarao Kotaru and Lakshmisowjanya Kotaru serve as directors at the Company.
- CIN/LLPIN
U74999TG2016PTC113597
- Company No.
113597
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kotaru Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasarao Kotaru  | Managing Director | 21-Dec-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakshmisowjanya Kotaru | Director | 21-Dec-2016 | Current |
Financial Performance of Kotaru Laboratories.
Kotaru Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.66% increase. The company also saw a substantial improvement in profitability, with a 29.39% increase in profit. The company's net worth Soared by an impressive increase of 81.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kotaru Laboratories?
In 2022, Kotaru Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 04 Jan 2023 | ₹5.50 Cr | Open |
Canara Bank Creation Date: 17 Nov 2020 | ₹1.05 M | Open |
Canara Bank Creation Date: 17 Nov 2020 | ₹2.00 Cr | Open |
How Many Employees Work at Kotaru Laboratories?
Unlock and access historical data on people associated with Kotaru Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kotaru Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kotaru Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
